LINDSAY E ELTON
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology CEDAR PARK, TX NPI 1013119130
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology TX UCB, Inc. All categories
General Payments — all program years on this page
$8,096.30
- Category: General Payments
- Program years: PY2018–2024
- Record count: 462
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,295.06 across 60 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,278.34 | 59 |
| Education | $16.72 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $214.39 | 9 |
| SK Life Science, Inc. | $165.83 | 7 |
| Corium, Inc. | $151.96 | 7 |
| Octapharma USA, Inc. | $71.31 | 4 |
| Vertical Pharmaceuticals, LLC | $70.45 | 4 |
| Ipsen Biopharmaceuticals, Inc | $61.87 | 2 |
| Noven Therapeutics, LLC | $60.81 | 3 |
| JAZZ PHARMACEUTICALS INC. | $57.49 | 3 |
| LivaNova USA, Inc. | $53.89 | 2 |
| Tris Pharma Inc | $43.10 | 2 |
| AQUESTIVE THERAPEUTICS, INC. | $41.36 | 2 |
| IRONSHORE PHARMACEUTICALS INC. | $40.06 | 2 |
| Neos Therapeutics, LP | $36.24 | 2 |
| ITF Therapeutics LLC | $33.56 | 1 |
| Biogen, Inc. | $25.23 | 1 |
| Neurelis, Inc. | $24.38 | 1 |
| Otter Pharmaceuticals, LLC | $23.08 | 1 |
| ABBVIE INC. | $21.42 | 1 |
| BIOCODEX, INC. | $19.88 | 1 |
| Supernus Pharmaceuticals, Inc. | $16.79 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 1 |
| Aucta Pharmaceuticals, Inc. | $15.75 | 1 |
| Pyros Pharmaceuticals, Inc. | $15.19 | 1 |
| Sumitomo Pharma America, Inc. | $14.30 | 1 |
By program year
Records — PY2024 (60)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.